Prevalence and Overlap of Potential Embolic Sources in Patients With Embolic Stroke of Undetermined Source

被引:113
作者
Ntaios, George [1 ]
Perlepe, Kalliopi [1 ]
Lambrou, Dimitrios [1 ]
Sirimarco, Gaia [2 ,3 ,4 ]
Strambo, Davide [2 ,3 ,4 ]
Eskandari, Ashraf [2 ,3 ,4 ]
Karagkiozi, Efstathia [1 ]
Vemmou, Anastasia [5 ]
Koroboki, Eleni [5 ]
Manios, Efstathios [5 ]
Makaritsis, Konstantinos [1 ]
Vemmos, Konstantinos [5 ]
Michel, Patrik [2 ,3 ,4 ]
机构
[1] Univ Thessaly, Larissa Univ Hosp, Sch Med, Dept Internal Med, Larisa, Greece
[2] CHU Vaudois, Dept Clin Neurosci, Stroke Ctr, Lausanne, Switzerland
[3] CHU Vaudois, Dept Clin Neurosci, Neurol Serv, Lausanne, Switzerland
[4] Univ Lausanne, Lausanne, Switzerland
[5] Alexandra Hosp, Med Sch Athens, Dept Clin Therapeut, Athens, Greece
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2019年 / 8卷 / 15期
关键词
atrial fibrillation; embolic stroke; embolic stroke of undetermined source; embolism; ATRIAL-FIBRILLATION PATIENTS; ISCHEMIC-STROKE; AORTIC-ARCH; RISK; DESIGN; RIVAROXABAN; RATIONALE; REGISTRY; ASPIRIN; RECURRENCE;
D O I
10.1161/JAHA.119.012858
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-We aimed to assess the prevalence and degree of overlap of potential embolic sources (PES) in patients with embolic stroke of undetermined source (ESUS). Methods and Results-In a pooled data set derived from 3 prospective stroke registries, patients were categorized in >= 1 groups according to the PES that was/were identified. We categorized PES as follows: atrial cardiopathy, atrial fibrillation diagnosed during follow-up, arterial disease, left ventricular disease, cardiac valvular disease, patent foramen ovale, and cancer. In 800 patients with ESUS (43.1% women; median age, 67.0 years), 3 most prevalent PES were left ventricular disease, arterial disease, and atrial cardiopathy, which were present in 54.4%, 48.5%, and 45.0% of patients, respectively. Most patients (65.5%) had >1 PES, whereas only 29.7% and 4.8% of patients had a single or no PES, respectively. In 31.1% of patients, there were >= 3 PES present. On average, each patient had 2 PES (median, 2). During a median follow-up of 3.7 years, stroke recurrence occurred in 101 (12.6%) of patients (23.3 recurrences per 100 patient-years). In multivariate analysis, the risk of stroke recurrence was higher in the atrial fibrillation group compared with other PES, but not statistically different between patients with 0 to 1, 2, or >= 3 PES. Conclusions-There is major overlap of PES in patients with ESUS. This may possibly explain the negative results of the recent large randomized controlled trials of secondary prevention in patients with ESUS and offer a rationale for a randomized controlled trial of combination of anticoagulation and aspirin for the prevention of stroke recurrence in patients with ESUS.
引用
收藏
页数:9
相关论文
共 29 条
[1]   Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading Role [J].
Alexopoulos, Dimitrios ;
Vlachakis, Panagiotis ;
Lekakis, John .
CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (03) :319-324
[2]   ATHEROSCLEROTIC DISEASE OF THE AORTIC-ARCH AND THE RISK OF ISCHEMIC STROKE [J].
AMARENCO, P ;
COHEN, A ;
TZOURIO, C ;
BERTRAND, B ;
HOMMEL, M ;
BESSON, G ;
CHAUVEL, C ;
TOUBOUL, PJ ;
BOUSSER, MG .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1474-1479
[3]   THE PREVALENCE OF ULCERATED PLAQUES IN THE AORTIC-ARCH IN PATIENTS WITH STROKE [J].
AMARENCO, P ;
DUYCKAERTS, C ;
TZOURIO, C ;
HENIN, D ;
BOUSSER, MG ;
HAUW, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04) :221-225
[4]   Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty [J].
Anderson, D. R. ;
Dunbar, M. ;
Murnaghan, J. ;
Kahn, S. R. ;
Gross, P. ;
Forsythe, M. ;
Pelet, S. ;
Fisher, W. ;
Belzile, E. ;
Dolan, S. ;
Crowther, M. ;
Bohm, E. ;
MacDonald, S. J. ;
Gofton, W. ;
Kim, P. ;
Zukor, D. ;
Pleasance, S. ;
Andreou, P. ;
Doucette, S. ;
Theriault, C. ;
Abianui, A. ;
Carrier, M. ;
Kovacs, M. J. ;
Rodger, M. A. ;
Coyle, D. ;
Wells, P. S. ;
Vendittoli, P. -A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (08) :699-707
[5]   Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial [J].
Andreas, Martin ;
Moayedifar, Roxana ;
Wieselthaler, Georg ;
Wolzt, Michael ;
Riebandt, Julia ;
Haberl, Thomas ;
Angleitner, Philipp ;
Schloeglhofer, Thomas ;
Wiedemann, Dominik ;
Schima, Heinrich ;
Laufer, Guenther ;
Zimpfer, Daniel .
CIRCULATION-HEART FAILURE, 2017, 10 (05)
[6]   Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial [J].
Bosch, Jackie ;
Eikelboom, John W. ;
Connolly, Stuart J. ;
Bruns, Nancy Cook ;
Lanius, Vivian ;
Yuan, Fei ;
Misselwitz, Frank ;
Chen, Edmond ;
Diaz, Rafael ;
Alings, Marco ;
Lonn, Eva M. ;
Widimsky, Petr ;
Hori, Masatsugu ;
Avezum, Alvaro ;
Piegas, Leopoldo S. ;
Bhatt, Deepak L. ;
Branch, Kelley R. H. ;
Probstfield, Jeffrey L. ;
Liang, Yan ;
Liu, Lisheng ;
Zhu, Jun ;
Maggioni, Aldo P. ;
Lopez-Jaramillo, Patricio ;
O'Donnell, Martin ;
Fox, Keith A. A. ;
Kakkar, Ajay ;
Parkhomenko, Alexander N. ;
Ertl, Georg ;
Stork, Stefan ;
Keltai, Katalin ;
Keltai, Matyas ;
Ryden, Lars ;
Dagenais, Gilles R. ;
Pogosova, Nana ;
Dans, Antonio L. ;
Lanas, Fernando ;
Commerford, Patrick J. ;
Torp-Pedersen, Christian ;
Guzik, Tomasz J. ;
Verhamme, Peter B. ;
Vinereanu, Dragos ;
Kim, Jae-Hyung ;
Ha, Jong-Won ;
Tonkin, Andrew M. ;
Varigos, John D. ;
Lewis, Basil S. ;
Felix, Camilo ;
Yusoff, Khalid ;
Steg, Philippe Gabriel ;
Aboyans, Victor .
CANADIAN JOURNAL OF CARDIOLOGY, 2017, 33 (08) :1027-1035
[7]   Embolic stroke of undetermined source: The role of the nonstenotic carotid plaque [J].
Bulwa, Zachary ;
Gupta, Ajay .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 382 :49-52
[8]   Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial [J].
Hart, Robert G. ;
Sharma, Mukul ;
Mundl, Hardi ;
Shoamanesh, Ashkan ;
Kasner, Scott E. ;
Berkowitz, Scott D. ;
Pare, Guillaume ;
Kirsch, Bodo ;
Pogue, Janice ;
Pater, Calin ;
Peters, Gary ;
Davalos, Antoni ;
Lang, Wilfried ;
Wang, Yongjun ;
Wang, Yilong ;
Cunha, Luis ;
Eckstein, Jens ;
Tatlisumak, Turgut ;
Shamalov, Nikolay ;
Mikulik, Robert ;
Lavados, Pablo ;
Hankey, Graeme J. ;
Czlonkowska, Anna ;
Toni, Danilo ;
Ameriso, Sebastian F. ;
Gagliardi, Rubens J. ;
Amarenco, Pierre ;
Bereczki, Daniel ;
Uchiyama, Shinichiro ;
Lindgren, Arne ;
Endres, Matthias ;
Brouns, Raf ;
Yoon, Byung-Woo ;
Ntaios, George ;
Veltkamp, Roland ;
Muir, Keith W. ;
Ozturk, Serefnur ;
Arauz, Antonio ;
Bornstein, Natan ;
Bryer, Alan ;
O'Donnell, Martin J. ;
Weitz, Jeffrey ;
Peacock, Frank ;
Themeles, Ellison ;
Connolly, Stuart J. .
EUROPEAN STROKE JOURNAL, 2016, 1 (03) :146-154
[9]   Embolic Stroke of Undetermined Source A Systematic Review and Clinical Update [J].
Hart, Robert G. ;
Catanese, Luciana ;
Perera, Kanjana S. ;
Ntaios, George ;
Connolly, Stuart J. .
STROKE, 2017, 48 (04) :867-872
[10]   Embolic strokes of undetermined source: the case for a new clinical construct [J].
Hart, Robert G. ;
Diener, Hans-Christoph ;
Coutts, Shelagh B. ;
Easton, J. Donald ;
Granger, Christopher B. ;
O'Donnell, Martini J. ;
Sacco, Ralph L. ;
Connolly, Stuart J. .
LANCET NEUROLOGY, 2014, 13 (04) :429-438